Dr. John Cush RheumNow
5 years 4 months ago
News: Triple DMARD Therapy Bested by Biologics in Swedish Registry
The Swedish Register compared outcomes of 1502 RA patients initiating either biologics plus MTX or triple therapy and showed similar rates of sustained remission.
https://t.co/7JJxGF1tHz https://t.co/ht6kAsJkb9
Dr. John Cush RheumNow
5 years 4 months ago
RheumNow Podcast – Heart, Lung & Liver (5.28.2021)
Dr Jack Cush reviews the news and journal reports from this past week on RheumNow.
https://t.co/a9fvgaJVnQ https://t.co/r3nbf2Ftdb
A recent metanalysis assessed the comparative efficacy of current first-line pharmacologic antiinflammatory interventions for gout flares and surmised that canakinumab and intravenous or intramuscular corticosteroids are superior to nonsteroidal antiinflammatory drugs [NSAIDs].
Dr. John Cush RheumNow
5 years 4 months ago
News: EULAR Guidelines on Intraarticular Therapy
EULAR has published evidence-based recommendations on the use of intra-articular therapies (IAT) based on the literature review and recommendations of a multidisciplinary international task force.
https://t.co/Z6vC0x9zY1 https://t.co/gVCWMIJxtu
Dr. John Cush RheumNow
5 years 4 months ago
Study of National inpatient sample database (2015 to 2017) showed the frequency of atrial fibrillation in rheumatic disease (RD) pts finding that AF frequency highest in gout followed by vasculitis, and PMR. RD Mortality was 2 fold higher with AF. https://t.co/enno6hrKOI
Lancet Respiratory Medicine has reported the results of the COLCORONA trial, showing that in patients with PCR-confirmed COVID-19 infection, colchicine led to a significantly lower rate of death or hospital admission from COVID.
Dr. John Cush RheumNow
5 years 4 months ago
A trial of sarilumab in 431 hospitalized COVID-19 patients on supplemental oxygen, Compared to placebo, sarilumab did not improve COVID outcomes https://t.co/postv1eK3F
Dr. John Cush RheumNow
5 years 4 months ago
Kidney biopsies in patients with lupus – how early and how often? Dr. Fogo and Dr.Hogan explain why a kidney biopsy is critical for diagnosis and characterization of kidney involvement by SLE #SLEEducatorsNetwork.
Sponsored by GSK US Medical Affairs
https://t.co/ta3hliB9ls https://t.co/hJE6BNlNqk
Dr. John Cush RheumNow
5 years 4 months ago
Pirfenidone, studied in 127 pts w/ CVD/CTD ILD, fibrotic interstitial pneumonia, chr hypersensitivity pneumonitis, & asbestoslung fibrosis. Pirefenidone had significantly less FVC% decline compared with placebo (p=0·043) https://t.co/H1s6ut4NhG
Dr. John Cush RheumNow
5 years 4 months ago
Dr. Samir V. Parikh from the #SLEEducatorsNetwork discusses the major treatment goals for lupus nephritis and the broader needs of the patient in this program- Defining Treatment Goals for Lupus Nephritis.
Sponsored by GSK US Medical Affairs
https://t.co/f2Y707H2kR https://t.co/4xMIBp2yEh
Dr. John Cush RheumNow
5 years 4 months ago
RNL 2021: Treatment Advances in SpA: Dr. Nigil Haroon
Dr. Nigil Haroon presents Treatment Advances in SpA at RheumNow Live 2021.
https://t.co/9ZA0loThx6
Dr. John Cush RheumNow
5 years 4 months ago
News: Methotrexate Impairs COVID Vax Response
https://t.co/M9d31UAxb7
Dr. John Cush RheumNow
5 years 4 months ago
New podcast up! Download wherever podcasts are available.
https://t.co/y95zS04pqw
Dr. John Cush RheumNow
5 years 4 months ago
News: Efficacy of 6 Weeks Antibiotics with Prosthetic Joint Infections
https://t.co/mSDEIKUL1h
